MIR4661: A Drug Target / Disease Biomarker (G100616245)
MIR4661: A Drug Target / Disease Biomarker
MIR4661, also known as interleukin-4661, is a protein that is expressed in various tissues throughout the body. It is a member of the interleukin-4 family, which includes proteins that play a critical role in the regulation of immune and inflammatory responses. MIR4661 has been shown to have a variety of functions, including regulating the production of immune cells, modulating the response of cancer cells to chemotherapy, and contributing to the development of autoimmune diseases.
One of the key functions of MIR4661 is its role in the regulation of T cell development and function. T cells are a type of immune cell that play a critical role in protecting the body against infection and disease. MIR4661 has been shown to promote the development and proliferation of T cells, as well as regulate their activation and differentiation.
In addition to its role in T cell development, MIR4661 has also been shown to play a critical role in the regulation of cancer cell growth and survival. Studies have shown that MIR4661 can inhibit the growth and survival of cancer cells, both in cell culture and in animal models of cancer. This may make it an attractive drug target for cancer researchers, as a potential treatment for a variety of diseases.
MIR4661 has also been shown to play a role in the development of autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis. These conditions involve the immune system attacking the body's own tissues, leading to inflammation and damage. MIR4661 has been shown to contribute to the development of autoimmune diseases by regulating the activity of immune cells and promoting the production of immune antibodies.
Despite its potential as a drug target, MIR4661 is still a relatively little-known protein. There is currently limited research on the specific mechanisms of its function, and more research is needed to fully understand its potential as a drug. Additionally, MIR4661 is not approved for any clinical uses, so further research is needed to determine its safety and effectiveness as a potential drug.
In conclusion, MIR4661 is a protein that has the potential to be a drug target or biomarker for a variety of diseases. Its role in T cell development and cancer cell growth makes it an attractive target for cancer researchers, while its role in autoimmune diseases may make it a potential treatment for a range of conditions. Further research is needed to fully understand its function and potential as a drug, and to determine its safety and effectiveness in clinical trials.
Protein Name: MicroRNA 4661
More Common Targets
MIR4662A | MIR4663 | MIR4664 | MIR4665 | MIR4666A | MIR4666B | MIR4667 | MIR4668 | MIR4669 | MIR4670 | MIR4671 | MIR4672 | MIR4673 | MIR4674 | MIR4675 | MIR4676 | MIR4677 | MIR4679-1 | MIR4679-2 | MIR4680 | MIR4681 | MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768
